NewAmsterdam Pharma Corporation
NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabolic diseases.
102 employees · est. 2019 · Aventura, United States
SQZ Biotechnologies
Unlocking the full potential of cell therapies for patients around the world
18 employees · est. 2013 · Watertown, United States
SQZ Biotechnologies is the older company (2019 vs 2013); NewAmsterdam Pharma Corporation is the larger of the two.
Side-by-Side Comparison
| Metric | NewAmsterdam Pharma Corporation | SQZ Biotechnologies |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2013 older |
| Headquarters | ||
| Headquarters | Aventura, United States | Watertown, United States |
| Employees | ||
| Employees | 102 larger | 18 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | IPO | Grant |
| Total Funding | ||
| Total Funding | $907.90M | $229.81M |
| Funding Rounds | ||
| Funding Rounds | 6 | 13 |
| Services | ||
| Services | Cardiovascular Disease Research, Development of Obicetrapib, Clinical Science on CETP Inhibition, Inducement Grants | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with High Cholesterol, Healthcare Providers, Cardiovascular Disease Patients, Research Institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Clinical-stage Development, Cardiometabolic Diseases, Transformative Therapies, Cholesteryl Ester Transfer Protein Inhibitor, LDL-C Lowering Therapy, Lipid-lowering Therapy, Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Patient Care Improvement, Statin Therapy, Late-stage Clinical Trials | Cell Therapies, Clinical-stage, Immune Tolerance, Solid Tumors, Autoimmune Diseases, Immune Responses, Cell Squeeze® Technology, Patient Experience, Therapeutics, Cancer, Infectious Diseases, Immune Reactions, Accelerated Production, Immune Therapy |
| Website | ||
| Website | newamsterdampharma.com | sqzbiotech.com |
About NewAmsterdam Pharma Corporation
NewAmsterdam Pharma Corporation is capturing the attention of the biopharma sector through its commitment to addressing unmet needs in cardiometabolic diseases. Established in 2019, this United States-based company is actively engaged in late-stage clinical trials. The company's primary focus is on...
About SQZ Biotechnologies
SQZ Biotechnologies is a clinical-stage biotechnology company with a focus on leveraging its proprietary Cell Squeeze® technology to revolutionize cell therapies for patients with cancer, autoimmune, and infectious diseases. The company aims to develop well-tolerated cell therapies that offer therap...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at NewAmsterdam Pharma Corporation and SQZ Biotechnologies — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at NewAmsterdam Pharma Co... and SQZ Biotechnologies — by email.
Frequently Asked Questions
Compare NewAmsterdam Pharma Corporation with someone else
Start typing a company name or domain.